首页
外语
计算机
考研
公务员
职业资格
财经
工程
司法
医学
专升本
自考
实用职业技能
登录
外语
Testing Times Researchers are working on ways to reduce the need for animal experiments, but new laws may increase the numbe
Testing Times Researchers are working on ways to reduce the need for animal experiments, but new laws may increase the numbe
admin
2010-01-10
133
问题
Testing Times
Researchers are working on ways to reduce the need for animal experiments, but new laws may increase the number of experiments needed.
The current situation
In an ideal world, people would not perform experiments on animals. For the people, they are expensive. For the animals, they are stressful and often painful.
That ideal world, sadly, is still some way away. People need new drugs and vaccines. They want protection from the toxicity of chemicals. The search for basic scientific answers goes on. Indeed, the European Commission is forging ahead with proposals that will increase the number of animal experiments carried out in the European Union, by requiring toxicity tests on every chemical approved for use within the union’s borders in the past 25 years.
Already, the commission has identified 140,000 chemicals that have not yet been tested. It wants 30,000 of these to be examined right away, and plans to spend between ~ 4 billion — 8 billion ($5 billion—10 billion) doing so. The number of animals used for toxicity testing in Europe will thus, experts reckon, quintuple (翻五倍) from just over lm a year to about 5m, unless they are saved by some dramatic advances in non-animal testing technology. At the moment, roughly 10% of European animal tests are for general toxicity, 35% for basic research, 45% for drugs and vaccines, and the remaining 10% a variety of uses such as diagnosing diseases.
Animal experimentation will therefore be around for some time yet. But the search for substitutes continues, and last weekend the Middle European Society for Alternative Methods to Animal Testing met in Linz, Austria, to review progress.
A good place to start finding alternatives for toxicity tests is the liver--the organ responsible for breaking toxic chemicals down into safer molecules that can then be excreted. Two firms, one large and one small, told the meeting how they were using human liver cells removed incidentally during surgery to test various substances for long-term toxic effects.
One way out of the problem
PrimeCyte, the small firm, grows its cells in cultures over a few weeks and doses them regularly with the substance under investigation. The characteristics of the cells are carefully monitored, to look for changes in their microanatomy.
Pfizer, the big firm, also doses its cultures regularly, but rather than studying individual cells in detail, it counts cell numbers. If the number of cells in a culture changes after a sample is added, that suggests the chemical in question is bad for the liver.
In principle, these techniques could be applied to any chemical. In practice, drugs (and, in the case of PrimeCyte, food supplements) are top of the list. But that might change if the commission has its way: those 140,000 screenings look like a lucrative market, although nobody knows whether the new tests will be ready for use by 2009, when the commission proposes that testing should start.
Other tissues, too, can be tested independently of animals. Epithelix, a small firm in Geneva, has developed an artificial version of the lining of the lungs. According to Huang Song, one of Epithelix’s researchers, the firm’s cultured cells have similar microanatomy to those found in natural lung linings, and respond in the same way to various chemical messengers. Dr. Huang says that they could be used in long-term toxicity tests of airborne chemicals and could also help identify treatments for lung diseases.
The immune system can be mimicked and tested, too. ProBioGen, a company based in Berlin, is developing an artificial human lymph node (淋巴结) which, it reckons, could have prevented the neardisastrous consequences of a drag trial held in Britain three months ago, in which (despite the drag having passed animal tests) six men suffered multiple organ failure and nearly died. The drug the men were given made their immune systems hyperactive. Such a response would, the firm’s scientists reckon, nave teen identified by their lymph node, which is made from cells that provoke the immune system into a response. ProBioGen’s lymph node could thus work better than animal testing.
A second alternative
Another way of cutting the number of animal experiments would be to change the way that vaccines are tested, according to Coenraad Hendriksen of the Netherlands Vaccine Institute. At the moment, all batches of vaccine are subject to the same battery of tests. Dr. Hendriksen argues that this is over-rigorous. When new vaccine cultures are made, belt-and-braces tests obviously need to be applied. But if a batch of vaccine is derived from an existing culture, he suggests that it need be tested only to make sure it is identical to the batch from which it is derived. That would require fewer test animals.
All this suggests that though there is still some way to go before drugs, vaccines and other substances can be tested routinely on cells rather than live animals, useful progress is being made. What is harder to see is how the use of animals might be banished from fundamental research.
Weighing the balance
In basic scientific research, where the object is to understand how, say, the brain works rather than to develop a drug to treat brain disease, the whole animal is often necessarily the object of study. Indeed, in some cases, scientific advances are making animal tests more valuable, rather than less. Geneticmodification techniques mean that mice and rats can be remodelled to make them exhibit illnesses that they would not normally suffer from. Also, genes for human proteins can be added to them, so that animal tests will more closely mimic human responses. This offers the opportunity to understand human diseases better, and to screen treatments before human trials begin. However, the very creation of these mutants (突变异种) counts as an animal experiment in its own right, so the number of experiments is increasing once again.
What is bad news for rodents, though, could be good news for primates. Apes and monkeys belong to the same group of mammals as humans, and are thus seen as the best subjects for certain sorts of experiment. To the extent that rodents can be "humanised", the number of primate experiments might be reduced.
Some people, of course, would like to see them eliminated altogether, regardless of the effect on useful research. On June 6th the British Union for the Abolition of Vivisection, an animal-rights group, called for the use of primates in research to be banned. For great apes, this has already happened. Britain, Austria, the Netherlands, New Zealand and Sweden have ended experiments on chimpanzees, gorillas, bonobos and orang-utans. Experiments on monkeys, though, are still permitted. And some countries have not banned experiments on apes. In America, for example, about 1,000 chimpanzees a year are used in research.
This is a difficult area. Great apes are man’s closest relatives, having parted company from the human family tree only a few million years ago. Hence it can be (and is) argued that they are indispensable for certain sorts of research. On the other hand, a recent study by Andrew Knight and his colleagues at Animal Consultants International, an animal-advocacy group, casts doubt on the claim that apes are used only for work of vital importance to humanity. Important papers tend to get cited as references in subsequent studies, so Mr. Knight looked into the number of citations received by 749 scientific papers published as a result of invasive experiments on captive chimpanzees. Half had received not a single citation up to ten years after their original publication.
That is damning. Animal experiments are needed for the advance of medical science, not to mention people’s safety. But if scientists are to keep the sympathy of the public, they need to do better than that.
People are trying to find alternatives to animal testing, and they started with liver.
选项
A、Y
B、N
C、NG
答案
A
解析
根据liver判断信息在第一部分最后一段,因此此叙述的内容正确
转载请注明原文地址:https://kaotiyun.com/show/QRt7777K
0
大学英语四级
相关试题推荐
A、Heagreeswiththewoman.B、Hehasn’tbeentoagamerecently.C、Hedoesn’tknowmuchaboutbasketball.D、Hedoesn’tthinkthe
A、Planningholidays.B、Workinginatravelagency.C、Travelingalone.D、FlyingtoNewYork.AW:Ifyouhaven’tyetdecidedonyo
Letusconsiderwhatscienceandtechnologyhavetocontributetothefoodproblem.Thesimplestwaytoincreasefoodproduc
Agoodtitleforthisarticlewouldbe______.Howdoesaspirinreducefever?
Forthispart,youareallowedthirtyminutestowriteacompositiononthetopic:OwningPrivateCars.Youshouldwriteatleas
A、Itincreasesdeathtollonthehighway.B、Itresultsintherapiddepletionofourresourcesofpetroleum.C、Itbringspolluti
Recently,somepeopleareinterestedinnaturalfoodsbecause______.Itissignificantthatnowadays______consideredtobea
A、Therelationshipofpurchasestotimespentinshopping.B、Thelengthoftimerequiredfordrugstoreshopping.C、Theincreases
Educationmakesourlivesricher.It【S1】______uswithopportunities.Sotheamountthatgirlswereallowedto【S2】______ined
随机试题
美国人的饮食比较随便,边吃边谈。喜欢吃西餐,对粤菜也情有独钟。()
Itisdifficulttoimaginewhatlifewouldbelikewithoutmemory.Themeaningsofthousandsofeverydayperceptions,thebasis
第二肝门指的是
A.平舌骨大角尖B.平舌骨大角稍下方C.平甲状软骨上缘D.平舌骨大角稍上方E.平下颌骨髁突颈部舌动脉自何处由颈外动脉发出()
A.胰岛素分泌不足B.甲状腺激素分泌过多C.促肾上腺皮质激素分泌增加D.婴幼儿甲状腺激素分泌不足E.生长激素及生长激素释放激素缺乏呆小症的原因是
一般资料:求助者,男性,16岁,高中一年级学生。案例介绍:求助者从小有咬指甲的习惯,多次受到父母的训斥。自己也很想改,但做了很多努力,没有明显效果,主动前来寻求帮助。下面是心理咨询师与该求助者之间的一段咨询对话:心理咨询师:通
主体通过对直接感知到的教学材料的表层意义、表面特征进行加工,形成对有关事物的具体的、特殊的、感性认识的过程称为()
贯彻执行按劳分配原则()。
新中国成立初期,中国共产党面临着许多严重的困难和一些紧迫的问题,致使新生的共和国急需解决的重大任务是()
A、Travelotherwise.B、Modifyhisreservation.C、Cancelhistravelplans.D、Awaitaplaneticket.D男士说:真是难以置信,我竟然买不到五月假期的机票。我是说现在
最新回复
(
0
)